Literature DB >> 28030663

Perioperative Major Adverse Cardiovascular and Cerebrovascular Events Associated With Noncardiac Surgery.

Nathaniel R Smilowitz1, Navdeep Gupta2, Harish Ramakrishna3, Yu Guo1, Jeffrey S Berger1, Sripal Bangalore1.   

Abstract

Importance: Major adverse cardiovascular and cerebrovascular events (MACCE) are a significant source of perioperative morbidity and mortality following noncardiac surgery. Objective: To evaluate national trends in perioperative cardiovascular outcomes and mortality after major noncardiac surgery and to identify surgical subtypes associated with cardiovascular events using a large administrative database of United States hospital admissions. Design, Setting, Participants: Patients who underwent major noncardiac surgery from January 2004 to December 2013 were identified using the National Inpatient Sample. Main Outcomes and Measures: Perioperative MACCE (primary outcome), defined as in-hospital, all-cause death, acute myocardial infarction (AMI), or acute ischemic stroke, were evaluated over time.
Results: Among 10 581 621 hospitalizations (mean [SD] patient age, 65.74 [12.32] years; 5 975 798 female patients 56.60%]) for major noncardiac surgery, perioperative MACCE occurred in 317 479 hospitalizations (3.0%), corresponding to an annual incidence of approximately 150 000 events after applying sample weights. Major adverse cardiovascular and cerebrovascular events occurred most frequently in patients undergoing vascular (7.7%), thoracic (6.5%), and transplant surgery (6.3%). Between 2004 and 2013, the frequency of MACCE declined from 3.1% to 2.6% (P for trend <.001; adjusted odds ratio [aOR], 0.95; 95% CI, 0.94-0.97) driven by a decline in frequency of perioperative death (aOR, 0.79; 95% CI, 0.77-0.81) and AMI (aOR, 0.87; 95% CI, 0.84-0.89) but an increase in perioperative ischemic stroke from 0.52% in 2004 to 0.77% in 2013 (P for trend <.001; aOR 1.79; CI 1.73-1.86). Conclusions and Relevance: Perioperative MACCE occurs in 1 of every 33 hospitalizations for noncardiac surgery. Despite reductions in the rate of death and AMI among patients undergoing major noncardiac surgery in the United States, perioperative ischemic stroke increased over time. Additional efforts are necessary to improve cardiovascular care in the perioperative period of patients undergoing noncardiac surgery.

Entities:  

Mesh:

Year:  2017        PMID: 28030663      PMCID: PMC5563847          DOI: 10.1001/jamacardio.2016.4792

Source DB:  PubMed          Journal:  JAMA Cardiol            Impact factor:   14.676


  23 in total

1.  Estimate of the global volume of surgery in 2012: an assessment supporting improved health outcomes.

Authors:  Thomas G Weiser; Alex B Haynes; George Molina; Stuart R Lipsitz; Micaela M Esquivel; Tarsicio Uribe-Leitz; Rui Fu; Tej Azad; Tiffany E Chao; William R Berry; Atul A Gawande
Journal:  Lancet       Date:  2015-04-26       Impact factor: 79.321

2.  Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.

Authors:  Margaret C Fang; Marcelo Coca Perraillon; Kaushik Ghosh; David M Cutler; Allison B Rosen
Journal:  Am J Med       Date:  2014-03-25       Impact factor: 4.965

Review 3.  Perioperative stroke.

Authors:  Magdy Selim
Journal:  N Engl J Med       Date:  2007-02-15       Impact factor: 91.245

4.  Third universal definition of myocardial infarction.

Authors:  Kristian Thygesen; Joseph S Alpert; Allan S Jaffe; Maarten L Simoons; Bernard R Chaitman; Harvey D White; Kristian Thygesen; Joseph S Alpert; Harvey D White; Allan S Jaffe; Hugo A Katus; Fred S Apple; Bertil Lindahl; David A Morrow; Bernard R Chaitman; Peter M Clemmensen; Per Johanson; Hanoch Hod; Richard Underwood; Jeroen J Bax; Jeroen J Bonow; Fausto Pinto; Raymond J Gibbons; Keith A Fox; Dan Atar; L Kristin Newby; Marcello Galvani; Christian W Hamm; Barry F Uretsky; Ph Gabriel Steg; William Wijns; Jean-Pierre Bassand; Phillippe Menasche; Jan Ravkilde; E Magnus Ohman; Elliott M Antman; Lars C Wallentin; Paul W Armstrong; Maarten L Simoons; James L Januzzi; Markku S Nieminen; Mihai Gheorghiade; Gerasimos Filippatos; Russell V Luepker; Stephen P Fortmann; Wayne D Rosamond; Dan Levy; David Wood; Sidney C Smith; Dayi Hu; Jose-Luis Lopez-Sendon; Rose Marie Robertson; Douglas Weaver; Michal Tendera; Alfred A Bove; Alexander N Parkhomenko; Elena J Vasilieva; Shanti Mendis; Jeroen J Bax; Helmut Baumgartner; Claudio Ceconi; Veronica Dean; Christi Deaton; Robert Fagard; Christian Funck-Brentano; David Hasdai; Arno Hoes; Paulus Kirchhof; Juhani Knuuti; Philippe Kolh; Theresa McDonagh; Cyril Moulin; Bogdan A Popescu; Zeljko Reiner; Udo Sechtem; Per Anton Sirnes; Michal Tendera; Adam Torbicki; Alec Vahanian; Stephan Windecker; Joao Morais; Carlos Aguiar; Wael Almahmeed; David O Arnar; Fabio Barili; Kenneth D Bloch; Ann F Bolger; Hans Erik Botker; Biykem Bozkurt; Raffaele Bugiardini; Christopher Cannon; James de Lemos; Franz R Eberli; Edgardo Escobar; Mark Hlatky; Stefan James; Karl B Kern; David J Moliterno; Christian Mueller; Aleksandar N Neskovic; Burkert Mathias Pieske; Steven P Schulman; Robert F Storey; Kathryn A Taubert; Pascal Vranckx; Daniel R Wagner
Journal:  J Am Coll Cardiol       Date:  2012-09-05       Impact factor: 24.094

5.  Relation of perioperative elevation of troponin to long-term mortality after orthopedic surgery.

Authors:  Brandon S Oberweis; Nathaniel R Smilowitz; Swetha Nukala; Andrew Rosenberg; Jinfeng Xu; Steven Stuchin; Richard Iorio; Thomas Errico; Martha J Radford; Jeffrey S Berger
Journal:  Am J Cardiol       Date:  2015-03-23       Impact factor: 2.778

6.  Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery.

Authors:  P J Devereaux; Matthew T V Chan; Pablo Alonso-Coello; Michael Walsh; Otavio Berwanger; Juan Carlos Villar; C Y Wang; R Ignacio Garutti; Michael J Jacka; Alben Sigamani; Sadeesh Srinathan; Bruce M Biccard; Clara K Chow; Valsa Abraham; Maria Tiboni; Shirley Pettit; Wojciech Szczeklik; Giovanna Lurati Buse; Fernando Botto; Gordon Guyatt; Diane Heels-Ansdell; Daniel I Sessler; Kristian Thorlund; Amit X Garg; Marko Mrkobrada; Sabu Thomas; Reitze N Rodseth; Rupert M Pearse; Lehana Thabane; Matthew J McQueen; Tomas VanHelder; Mohit Bhandari; Jackie Bosch; Andrea Kurz; Carisi Polanczyk; German Malaga; Peter Nagele; Yannick Le Manach; Martin Leuwer; Salim Yusuf
Journal:  JAMA       Date:  2012-06-06       Impact factor: 56.272

Review 7.  Perioperative Management to Reduce Cardiovascular Events.

Authors:  Nathaniel R Smilowitz; Jeffrey S Berger
Journal:  Circulation       Date:  2016-03-15       Impact factor: 29.690

8.  Risk of major adverse cardiac events following noncardiac surgery in patients with coronary stents.

Authors:  Mary T Hawn; Laura A Graham; Joshua S Richman; Kamal M F Itani; William G Henderson; Thomas M Maddox
Journal:  JAMA       Date:  2013-10-09       Impact factor: 56.272

9.  The healthcare cost and utilization project: an overview.

Authors:  Claudia Steiner; Anne Elixhauser; Jenny Schnaier
Journal:  Eff Clin Pract       Date:  2002 May-Jun

10.  Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials.

Authors:  Sripal Bangalore; Sunil Kumar; Mario Fusaro; Nicholas Amoroso; Michael J Attubato; Frederick Feit; Deepak L Bhatt; James Slater
Journal:  Circulation       Date:  2012-05-14       Impact factor: 29.690

View more
  56 in total

1.  Trends in cardiovascular risk factor and disease prevalence in patients undergoing non-cardiac surgery.

Authors:  Nathaniel R Smilowitz; Navdeep Gupta; Yu Guo; Joshua A Beckman; Sripal Bangalore; Jeffrey S Berger
Journal:  Heart       Date:  2018-01-05       Impact factor: 5.994

Review 2.  Perioperative myocardial injury and the contribution of hypotension.

Authors:  Daniel I Sessler; Ashish K Khanna
Journal:  Intensive Care Med       Date:  2018-06-04       Impact factor: 17.440

3.  Overlap in Age at the Time of Elective Percutaneous Coronary Intervention and at Noncardiac Surgery.

Authors:  Nathaniel R Smilowitz; Jeffrey S Berger; Joshua A Beckman; Sripal Bangalore
Journal:  J Am Coll Cardiol       Date:  2018-09-25       Impact factor: 24.094

Review 4.  Non-cardiac surgery in patients with coronary artery disease: risk evaluation and periprocedural management.

Authors:  Davide Cao; Rishi Chandiramani; Davide Capodanno; Jeffrey S Berger; Matthew A Levin; Mary T Hawn; Dominick J Angiolillo; Roxana Mehran
Journal:  Nat Rev Cardiol       Date:  2020-08-05       Impact factor: 32.419

5.  Perioperative bleeding and thrombotic risks in patients with Von Willebrand disease.

Authors:  Nathaniel R Smilowitz; Navdeep Gupta; Yu Guo; Sripal Bangalore; Jeffrey S Berger
Journal:  J Thromb Thrombolysis       Date:  2017-07       Impact factor: 2.300

6.  Association of Thrombocytopenia, Revascularization, and In-Hospital Outcomes in Patients with Acute Myocardial Infarction.

Authors:  Gregory D Rubinfeld; Nathaniel R Smilowitz; Jeffrey S Berger; Jonathan D Newman
Journal:  Am J Med       Date:  2019-04-27       Impact factor: 4.965

7.  Cardiovascular Outcomes of Patients With Pulmonary Hypertension Undergoing Noncardiac Surgery.

Authors:  Nathaniel R Smilowitz; Andrew Armanious; Sripal Bangalore; Harish Ramakrishna; Jeffrey S Berger
Journal:  Am J Cardiol       Date:  2019-02-08       Impact factor: 2.778

8.  Systemic lupus erythematosus and the risk of perioperative major adverse cardiovascular events.

Authors:  Nathaniel R Smilowitz; Gregory Katz; Jill P Buyon; Robert M Clancy; Jeffrey S Berger
Journal:  J Thromb Thrombolysis       Date:  2018-01       Impact factor: 2.300

9.  High-Sensitivity Troponin in Noncardiac Surgery: Pandora's Box or Opportunity for Precision Perioperative Care?

Authors:  Aditya Mandawat; L Kristin Newby
Journal:  Circulation       Date:  2018-03-20       Impact factor: 29.690

10.  Atrial Septal Defect and the Risk of Ischemic Stroke in the Perioperative Period of Noncardiac Surgery.

Authors:  Nathaniel R Smilowitz; Varun Subashchandran; Jeffrey S Berger
Journal:  Am J Cardiol       Date:  2019-07-15       Impact factor: 2.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.